This web site is no longer being updated. For more information, please contact one of the organizations listed on the Contact Page.
This Web site (www.treatHIVglobally.ca) aims to improve access to HIV/AIDS treatment information to people across Canada and around the world, by providing information in several of the world’s major languages.
From this “portal”, you will be directed to an extensive range of HIV/AIDS treatment information in 10 languages. The information is simple to read and easy to download and print. We have linked information in different languages so that it can readily be shared between people, even when they speak different languages. There is also a multilingual glossary of HIV terms with definitions and translations into 12 languages.
Toronto is one of the most culturally and linguistically diverse cities in the world. People living with HIV/AIDS (PHAs) from may ethno-racial communities experience significant language barriers in accessing HIV treatment information. There are also gaps in treatment information available in many languages internationally. The lack of information often affects PHAs' choice of, usage of, and adherence to HIV treatments.
The success of an action research project conducted by Asian Community AIDS Services in Toronto, in collaboration with Canadian AIDS Treatment Information Exchange (CATIE), to improve treatment access through culturally appropriate and linguistically specific resource development has led to a broader collaboration with other ethno-racial AIDS Services organizations in the past few years.
At present, this Web site is the result of the collaborative efforts of the following agencies:
The partner organizations would like to thank the many people and organizations for their support in making this Web site possible, including our many translators and proof readers and our talented graphic designers.
Production of this Web site has been made possible through financial contributions from the following agencies:
Some of the translation work was also funded through unrestricted educational grants from GlaxoSmithKline in partnership with Shire BioChem.